Clinical guidelines for the management of osteoporosis in China: a systematic review.

What was studied

This review compared guidelines for osteoporosis care in China. The team searched English and Chinese sources up to 13 August 2026. They kept guidelines for primary osteoporosis in Chinese adults. Each guideline was rated with a standard tool. 32 guidelines from over 60 medical groups were included.

What they found

The guidelines agreed on how to define osteoporosis. They also agreed on how to diagnose it and how to prevent it. They also agreed that care should include both drug and non-drug methods. But they differed on some treatment advice. This often reflected the focus of each field, such as orthopaedics or geriatrics. Only some covered fracture liaison services and cost-effectiveness.

What it means for patients

The team said the review shows gaps in agreement between the guidelines. They said more high-quality research is needed. They also said cost data should be used more. This would help build more coherent national guidelines.

Why it is not certain yet

This review compares guidelines. It does not test any treatment. English and Chinese sources were searched. The guidelines came from many fields with different aims.

Source

Clinical guidelines for the management of osteoporosis in China: a systematic review.

We restate facts from the source record in our own words. The original wording belongs to its publisher.